Fig. 5From: Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemiaDisease-free survival comparison among CDKN2 deletion patients received immunophenotypic analysis. Kaplan–Meier Curve demonstrated a significantly shorter disease-free survival time in CDKN2 deletion patients with CD20-positive patients than in CDKN2 deletion with CD20-negative patients (P = 0.023). CR complete remissionBack to article page